Daniel P. Silver

10.7k total citations · 1 hit paper
36 papers, 3.9k citations indexed

About

Daniel P. Silver is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Daniel P. Silver has authored 36 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Genetics. Recurrent topics in Daniel P. Silver's work include DNA Repair Mechanisms (15 papers), BRCA gene mutations in cancer (11 papers) and PARP inhibition in cancer therapy (8 papers). Daniel P. Silver is often cited by papers focused on DNA Repair Mechanisms (15 papers), BRCA gene mutations in cancer (11 papers) and PARP inhibition in cancer therapy (8 papers). Daniel P. Silver collaborates with scholars based in United States, Denmark and France. Daniel P. Silver's co-authors include David M. Livingston, David Baltimore, Eugenia Spanopoulou, Ralph Scully, Ronald A. DePinho, Zoltán Szállási, Nicolai J. Birkbak, Andrea L. Richardson, Aron C. Eklund and Junjie Chen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Daniel P. Silver

35 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

2004 626 citations David A. Tuveson, Alice T. Shaw et al. Cancer Cell profile →

Peers

Countries citing papers authored by Daniel P. Silver

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Silver more than expected).

Fields of papers citing papers by Daniel P. Silver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Silver. The network helps show where Daniel P. Silver may publish in the future.

Co-authorship network of co-authors of Daniel P. Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Silver. A scholar is included among the top collaborators of Daniel P. Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Silver. Daniel P. Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PARP Inhibitors for the Treatment of BRCA1/ 2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis 2023 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), Daniel P. Silver, Maysa Abu‐Khalaf	3
2	Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer 2021 ·npj Breast Cancer ·Rui Luo, Weelic Chong, Qiang Wei, Zhenchao Zhang, Chun Wang, Zhong Ye, Maysa Abu‐Khalaf, Daniel P. Silver, (unknown), Wei Jiang, Ronald E. Myers, Bingshan Li, Massimo Cristofanilli, Hushan Yang	26
3	Duodenal and Biliary Obstruction due to Extrinsic Compression by Recurrent Lobular Breast Carcinoma: A Case Report 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Harish Lavu, Thomas E. Kowalski, Daniel P. Silver	1
4	Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis 2019 ·Clinical Cancer Research ·Melinda L. Telli, Charles C. Chu, Sunil Badve, Shaveta Vinayak, Daniel P. Silver, Steven J. Isakoff, Virginia Kaklamani, William J. Gradishar, Vered Stearns, Roisín M. Connolly, James M. Ford, Joshua J. Gruber, Sylvia Adams, Judy E. Garber, Nadine Tung, Chris Neff, Ryan Bernhisel, Kirsten M. Timms, Andrea L. Richardson	23
5	Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers 2018 ·Annals of Oncology ·Nicolai J. Birkbak, Y. Li, Shailja Pathania, April Greene-Colozzi, Matija Dreze, Christian Bowman-Colin, Zsófia Sztupinszki, Marcin Krzystanek, Miklós Dióssy, Nadine Tung, Paula D. Ryan, Judy E. Garber, Daniel P. Silver, J. Dirk Iglehart, Zhicheng Wang, Dávid Szüts, Zoltán Szállási, Andrea L. Richardson	47
6	Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells 2017 ·Breast Cancer Research ·Jessalyn M. Ubellacker, Marie‐Therese Haider, Molly J. DeCristo, (unknown), Nicola J. Brown, Daniel P. Silver, Ingunn Holen, Sandra S. McAllister	29
7	MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy 2015 ·Cancer Discovery ·Manish Neupane, Allison Clark, Serena Landini, Nicolai J. Birkbak, Aron C. Eklund, Elgene Lim, Aedín C. Culhane, William T. Barry, Steven E. Schumacher, Rameen Beroukhim, Zoltán Szállási, Marc Vidal, David E. Hill, Daniel P. Silver	49
8	Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs 2015 ·Biomarker Research ·Andrea Marion Marquard, Aron C. Eklund, Tejal Joshi, Marcin Krzystanek, Francesco Favero, Zhigang C. Wang, Andrea L. Richardson, Daniel P. Silver, Zoltán Szállási, Nicolai J. Birkbak	180
9	Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans 2013 ·Clinical Infectious Diseases ·Daniel P. Silver, (unknown), Anu Osinusi, Rachel Silk, Lara Stabinski, (unknown), Sarah Henn, (unknown), Henry Masur, Shyam Kottilil, Dawn Fishbein	7
10	Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents 2012 ·Cancer Discovery ·Nicolai J. Birkbak, Zhigang C. Wang, Ji-Young Kim, Aron C. Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J. Dirk Iglehart, Nadine Tung, Paula D. Ryan, Judy E. Garber, Daniel P. Silver, Zoltán Szállási, Andrea L. Richardson	412
11	Mechanisms of BRCA1 Tumor Suppression 2012 ·Cancer Discovery ·Daniel P. Silver, David M. Livingston	100
12	Poly ADP-ribose polymerase inhibitors: science and current clinical development 2010 ·Current Opinion in Oncology ·Joyce F. Liu, Daniel P. Silver	5
13	Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells 2009 ·Cell ·Ilona Kalaszczyńska, Yan Geng, Tadafumi Iino, (unknown), Yoon Jong Choi, Ilona Kondratiuk, Daniel P. Silver, Debra J. Wolgemuth, Koichi Akashi, Piotr Siciński	157
14	Abnormalities of the Inactive X Chromosome Are a Common Feature of BRCA1 Mutant and Sporadic Basal-like Breast Cancer 2005 ·Cold Spring Harbor Symposia on Quantitative Biology ·Shridar Ganesan, Andrea L. Richardson, (unknown), J. Dirk Iglehart, Alexander Miron, Jean Feunteun, Daniel P. Silver, David M. Livingston	17
15	The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·L. Nathan Tumey, David Bom, Bayard R. Huck, (unknown), Jianmin Wang, Daniel P. Silver, Kurt R. Brunden, Sherry Boozer, Stephen E. Rundlett, Bruce A. Sherf, Steven M. Murphy, (unknown), (unknown), (unknown), John Harrington, Youssef L. Bennani	70
16	Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects breakdown → 2004 ·Cancer Cell ·David A. Tuveson, Alice T. Shaw, Nicholas A. Willis, Daniel P. Silver, Erica L. Jackson, Sandy Chang, Kim L. Mercer, Rebecca Grochow, Hanno Hock, Denise Crowley, Sunil R. Hingorani, Tal Zaks, Catrina E. King, Michael A. Jacobetz, Lifu Wang, Roderick T. Bronson, Stuart H. Orkin, Ronald A. DePinho, Tyler Jacks	626
17	BRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome 2002 ·Cell ·Shridar Ganesan, Daniel P. Silver, Roger A. Greenberg, Dror Avni, Ronny Drapkin, Alexander Miron, Samuel C. Mok, Voahangy Randrianarison, Steven G. Brodie, Jennifer L. Salstrom, Theodore P. Rasmussen, (unknown), (unknown), York Marahrens, Chu‐Xia Deng, Jean Feunteun, David M. Livingston	226
18	Self-Excising Retroviral Vectors Encoding the Cre Recombinase Overcome Cre-Mediated Cellular Toxicity 2001 ·Molecular Cell ·Daniel P. Silver, David M. Livingston	242
19	Stable Interaction between the Products of the BRCA1 and BRCA2 Tumor Suppressor Genes in Mitotic and Meiotic Cells 1998 ·Molecular Cell ·Junjie Chen, Daniel P. Silver, Deepika Walpita, Sharon B. Cantor, Adi F. Gazdar, Gail E. Tomlinson, Fergus J. Couch, Barbara L. Weber, Terry Ashley, David M. Livingston, Ralph Scully	485
20	Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2 1995 ·Immunity ·Eugenia Spanopoulou, Patricia Cortés, Charles C.-Y. Shih, (unknown), Daniel P. Silver, Pamela Svec, David Baltimore	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact